Cellebrite (CLBT) director Troy Richardson reports 20,974-share ownership

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Troy Richardson filed an initial ownership report showing he holds 20,974 Ordinary Shares. This is a Form 3 filing, which establishes his starting stake as a company insider rather than reporting any new trade.

The position includes 10,601 Ordinary Shares represented by restricted share units granted on September 17, 2025, which are scheduled to vest on September 17, 2026. Each restricted unit converts into one Ordinary Share when it settles, so part of his reported holdings is still subject to future vesting.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Richardson Troy

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")	20,974(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

	/s/ Troy Richardson	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Troy Richardson’s Form 3 filing for Cellebrite (CLBT) show?

The Form 3 shows Troy Richardson’s initial ownership in Cellebrite as a director. He reports 20,974 Ordinary Shares, including restricted share units that will vest in the future, establishing his baseline stake as he becomes a reporting insider.

How many Cellebrite (CLBT) shares does Troy Richardson report owning?

Troy Richardson reports holding 20,974 Ordinary Shares of Cellebrite. This total combines currently held shares and shares underlying restricted share units, giving investors a clear picture of his overall equity interest as disclosed in the filing.

What restricted share units are included in Troy Richardson’s Cellebrite (CLBT) holdings?

His position includes 10,601 Ordinary Shares represented by restricted share units. These RSUs were granted on September 17, 2025 and vest on September 17, 2026, meaning part of his reported holdings depends on future vesting.

Does Troy Richardson’s Cellebrite (CLBT) Form 3 report any recent share purchases or sales?

The Form 3 does not report any new purchases or sales. It serves as an initial statement of ownership, listing Troy Richardson’s existing 20,974 Ordinary Shares, including unvested restricted share units, when he became subject to insider reporting.

Why is Troy Richardson’s Cellebrite (CLBT) Form 3 important for investors?

The filing establishes Troy Richardson’s starting equity stake as a director, showing 20,974 Ordinary Shares including RSUs. Knowing how many shares an insider holds helps investors understand management’s direct exposure to the company’s performance.